Soybean trypsin inhibitor and cerulein accelerate recovery of cerulein-induced pancreatitis in rats.
The role of exogenous and endogenous cholecystokinin has been studied in the process of pancreatic regeneration after acute pancreatitis. A mild form of pancreatitis was induced in rats by subcutaneous cerulein at 12 micrograms.kg-1, three times a day for 2 days. After 3 days of rest, the cerulein-treated rats were divided into four groups: rats with acute pancreatitis fed 20% casein, who received no treatment; rats fed 50% casein; rats fed 20% casein supplemented with 1% soybean trypsin inhibitor (SBTI); and rats fed 20% casein who received 1 microgram.kg-1 of subcutaneous cerulein, three times a day. Controls were fed 20% casein plus saline subcutaneously. Rats were killed after 5, 10, or 20 days of treatment. Pancreatitis resulted in significant decreases in pancreatic weight and contents of protein, amylase, chymotrypsin, RNA and DNA. During the regenerative process, 1 microgram.kg-1 of cerulein increased all parameters to control values within 5 days and induced pancreatic growth thereafter. SBTI restored the pancreas to normal after 10 days with cellular hypertrophy; the 50% casein diet gave a response similar to SBTI without hypertrophy. It can be concluded that cerulein and SBTI can accelerate pancreatic regeneration after an attack of acute pancreatitis.
Département de Biologie, Faculté des Sciences, Université de Sherbrooke, Québec, Canada.
G
G
Jurkowska
G
G
Grondin
S
S
Massé
J
J
Morisset
D000208:Acute Disease; D000681:Amylases / Q000378:metabolism; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002108:Ceruletide / Q000627:therapeutic use*; D002766:Cholecystokinin / Q000494:pharmacology / Q000502:physiology*; D002918:Chymotrypsin / Q000378:metabolism; D004359:Drug Therapy, Combination; D006984:Hypertrophy / Q000139:chemically induced; D008297:Male; D009696:Nucleic Acids / Q000378:metabolism; D009929:Organ Size / Q000187:drug effects; D010179:Pancreas / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D010195:Pancreatitis / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D011506:Proteins / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D012038:Regeneration / Q000187:drug effects; D013025:Glycine max; D014361:Trypsin Inhibitors / Q000627:therapeutic use*
D009696:Nucleic Acids; D011506:Proteins; D014361:Trypsin Inhibitors; D002108:Ceruletide; D002766:Cholecystokinin; D000681:Amylases; D002918:Chymotrypsin